![Jason Cavalier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 359 927 $ al 30/06/2026
Jason Cavalier is currently Chief Financial & Accounting Officer at Lyra Therapeutics, Inc. since 2026.
Formerly, Mr. Cavalier was Director-Mergers & Acquisitions at RBC Capital Markets LLC from 2009 to 2017 and MD, Head-Life Sciences Mergers & Acquisitions at Cantor Fitzgerald & Co. from 2017 to 2021.
Education includes an undergraduate degree from Cornell University and an MBA from Columbia Business School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LYRA THERAPEUTICS, INC. 29,18 % | 01/04/2026 | 517.880 ( 29,18 % ) | 359 927 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| LYRA THERAPEUTICS, INC. | Director Financiero/CFO | 13/09/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
Cantor Fitzgerald & Co.
 Cantor Fitzgerald & Co. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/05/2021 |
RBC Capital Markets LLC
 RBC Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/04/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Cantor Fitzgerald & Co.
Cantor Fitzgerald & Co. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RBC Capital Markets LLC
RBC Capital Markets LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Lyra Therapeutics, Inc.
 Lyra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage therapeutics company which develops and commercializes novel integrated drugs for treatment of patients with ear, nose and throat and ENT diseases | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
